Aspartate aminotransferase (AST) is an enzyme that lives inside cells, especially in the liver, heart, skeletal muscles, and kidneys. An AST blood test measures how much AST has leaked into the bloodstream. Because AST is released when cells are stressed, inflamed, or damaged, the test acts as a marker of tissue injury rather than measuring the enzyme’s normal metabolic role inside healthy cells.

An AST test is commonly ordered to spot early liver stress or damage before symptoms become severe. It can help explain fatigue, abdominal discomfort, unexplained weakness, or jaundice by providing objective evidence of cell injury. AST is also used to guide treatment decisions in liver disease, alcohol use, and medication-related toxicity, and to track liver health trends over time during chronic disease management.

Most laboratories list a typical AST reference range of about 10 to 40 units per liter, though cutoffs can vary slightly by lab. “Optimal” AST often falls in the lower half of that reference range, suggesting minimal ongoing liver, heart, or muscle cell breakdown. Trends matter: stable AST over time usually reflects consistent cellular integrity and better overall metabolic balance than fluctuating or rising values.

High AST usually means accelerated cell breakdown in the liver, heart, or skeletal muscle. Common liver-related causes include alcohol use, viral hepatitis, fatty liver disease, and medication toxicity. Non-liver causes include heart muscle injury (such as a heart attack) and muscle damage from intense exercise, trauma, or rhabdomyolysis. The degree of elevation and comparison with ALT help narrow the source.

Very high AST - sometimes around ten times above normal - can indicate acute liver damage or heart muscle death. The higher the AST, the more likely there is significant tissue injury requiring prompt evaluation. Symptoms such as marked fatigue, abdominal pain, dark urine, or jaundice may appear when liver function is compromised. Clinicians interpret AST alongside ALT and symptoms to determine urgency and likely cause.

AST and ALT are both enzymes that rise with cellular injury, but ALT is more liver-focused, while AST is found in many tissues (liver, heart, and muscles). Because AST is less specific, doctors often interpret AST with ALT to identify whether the problem is primarily hepatocellular (liver) versus more consistent with muscle or cardiac sources. The AST-to-ALT relationship improves diagnostic accuracy.

Yes. AST is abundant in skeletal muscle and heart tissue, so strenuous exercise, muscle trauma, rhabdomyolysis, or a recent heart attack can raise AST without primary liver disease. That’s why elevated AST doesn’t automatically mean liver damage. Clinicians typically compare AST with ALT and other cardiac markers when relevant, then use symptoms and history (exercise, injury, chest pain) to pinpoint the source.

Low AST is uncommon and usually not clinically significant. It generally suggests normal liver and muscle cell integrity because AST is mainly released when cells are damaged. Very low AST can occasionally appear with severe vitamin B6 deficiency, since AST requires B6 as a cofactor. Low AST has also been noted in some people on dialysis. On its own, low AST rarely causes symptoms.

AST can rise temporarily after strenuous exercise or intramuscular injections, which may not reflect disease. Hemolysis (breakdown of red blood cells) during blood collection can also falsely elevate AST, making results appear higher than your true level. Pregnancy does not significantly change AST in healthy women based on this context. Interpreting AST with ALT and clinical context helps reduce misinterpretation from transient or technical factors.

AST is rarely interpreted alone because it can come from liver, heart, or muscle sources. Pairing AST with ALT helps distinguish liver-predominant injury from muscle or cardiac contributions. Interpretation is further improved when viewed alongside alkaline phosphatase and your symptoms, history (alcohol use, medications, viral hepatitis risk), and trends over time. This combined approach better identifies hidden organ stress and guides treatment decisions.